Two new members of mycophenolic acid family from penicillium brevicompactum dierckx

Journal of Antibiotics

Volumn 62, Issue 9, 2009, Pages 527-529

  Lu, Xinhua ^a,b   Zheng, Zhihui ^b   Zhang, Hua ^b   Huo, Changhong ^a   Dong, Yuesheng ^b   Ma, Ying ^b   Ren, Xiao ^b   Ke, Aibing ^b   He, Jiangong ^b   Gu, Yucheng ^a,c   Shi, Qingwen ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b North China Pharmaceutical Corporation   (China)

^c JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

IMPDH inhibitor; Mycophenolic acid; Mycophenolic derivatives

Indexed keywords

6 [ 3, 7 DIMETHYL 8 OXA 2 NONEN 1 YL] 7 HYDROXY 5 METHOXY 4 METHYL 1(3H) ISOBENZOFURANONE; 8 (1,3 DIHYDRO 4 HYDROXY 6 METHOXY 7 METHYL 3 OXA 5 ISOBENZOFURANYL) 2,6 DIMETHYL 6 OCTENOIC ACID; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; FUNGAL STRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PENICILLIUM; PENICILLIUM BREVICOMPACTUM; PRIORITY JOURNAL;

CELL PROLIFERATION; CHINA; ENZYME INHIBITORS; IMP DEHYDROGENASE; MYCELIUM; MYCOPHENOLIC ACID; PENICILLIUM; SOIL MICROBIOLOGY;

PENICILLIUM BREVICOMPACTUM;

EID: 70349582976     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2009.54     Document Type: Article

References (16)

1. Jackson, R. C., Weber, G. & Morris, H. P. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 256, 331-333 (1975).
2. Shu, Q. N. & Nair, V. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery. Med. Res. Rev. 28, 219-232 (2008).
3. Hood, K. A. & Zarembski, D. G. Mycophenolate mofetil: a unique immuno-suppressive agent. Am. J. Health Syst. Pharm. 54, 285-294 (1997).
4. Ishikawa, H. Mizoribine and mycophenolate mofetil. Curr. Med. Chem. 6, 575-597 (1999).
5. Jain, J. et al. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5¢-monophosphate dehydrogenase inhibitor. J. Pharmacol. Exp. Ther. 302, 1272-1277 (2002).
6. Floryk, D. & Thompson, T. C. Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells. Int. J. Cancer 123, 2294-2302 (2008).
7. Arai, M. et al. Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent. Bioorg. Med. Chem. 16, 6732-6769 (2008).
8. Franklin, T. J., Jacobs, V., Bruneau, P. & Ple, P. Glucuronidation by human colorectal adenocarcinoma cells as a mechanism of resistance to mycophenolic acid. Adv. Enz. Regul. 35, 91-100 (1995).
9. Jones, C. E., Taylor, P. J., McEwan, A. G. & Hanson, G. R. Spectroscopic characterization of copper (II) binding to the immunosuppressive drug mycophenolic acid. J. Am. Chem. Soc. 128, 9378-9386 (2006).
10. Habib, E. et al. Mycophenolic derivatives from Eupenicilliumparvum. J. Nat. Prod. 71, 1915-1918 (2008).
11. Magasanik, B., Moyed, H. S. & Gehring, L. B. Enzymes essential for the biosynthesis of nucleic acid guanine; inosine 5¢-phosphate dehydrogenase of Aerobacter aerogenes. J. Biol. Chem. 226, 339-350 (1957).
12. Domhan, S. et al. Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol. Cancer Ther. 7, 1656-1668 (2008).
13. Batovska, D. I. et al. Hydroxamic acid derivatives of mycophenolic acid inhibit histone deacetylase at the cellular level. Biosci. Biotechnol. Biochem. 72, 2623-2631 (2008).
14. Hideaki, U. et al. Mycophenolic acid inhibits syncytium formation accompanied by reduction of gp120 expression. J. Antibiot. 58, 514-518 (2005).
15. Ubukata, M. et al. Mycophenolic acid as a latent agonist of PPARgamma. Bioorg. Med. Chem. Lett. 17, 4767-4770 (2007).
16. Gulyas, E. et al. Method for producing impurity level in mycophenolic acid fermentation. US 20080254520 Oct. 16, (2008).